For research use only. Not for therapeutic Use.
CCG-203586 (Cat No.: I024241) is a small-molecule inhibitor that targets the Rho/MRTF/SRF transcriptional pathway, which plays a key role in fibrosis, cancer progression, and inflammatory responses. By inhibiting myocardin-related transcription factor (MRTF) activity, CCG-203586 suppresses the expression of genes involved in myofibroblast activation and extracellular matrix production. It is primarily used in preclinical studies to explore therapeutic strategies for fibrotic diseases such as systemic sclerosis and pulmonary fibrosis. CCG-203586 serves as a valuable tool for investigating MRTF-mediated signaling and antifibrotic drug development.
CAS Number | 1430611-23-6 |
Synonyms | CCG-203586; CCG203586; CCG 203586; EtDO-PIP2; EtDOPIP2; EtDO PIP2; |
Molecular Formula | C26H32N2O4 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | 2-(2,3-dihydro-1H-inden-2-yl)-N-((1R,2R)-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)acetamide |
InChI | InChI=1S/C26H32N2O4/c29-25(15-18-13-19-5-1-2-6-20(19)14-18)27-22(17-28-9-3-4-10-28)26(30)21-7-8-23-24(16-21)32-12-11-31-23/h1-2,5-8,16,18,22,26,30H,3-4,9-15,17H2,(H,27,29)/t22-,26-/m1/s1 |
InChIKey | WXPGOGVMRCVPDZ-ATIYNZHBSA-N |
SMILES | O=C(N[C@H](CN1CCCC1)[C@@H](C2=CC=C(OCCO3)C3=C2)O)CC4CC5=C(C=CC=C5)C4 |
Reference | 1: Arthur JR, Wilson MW, Larsen SD, Rockwell HE, Shayman JA, Seyfried TN. Ethylenedioxy-PIP2 oxalate reduces ganglioside storage in juvenile Sandhoff disease mice. Neurochem Res. 2013 Apr;38(4):866-75. doi: 10.1007/s11064-013-0992-5. Epub 2013 Feb 16. PMID: 23417430; PMCID: PMC6554746. |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |